(ULTA) Ulta Beauty - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US90384S3031
Stock:
Total Rating 72
Risk 38
Buy Signal 0.39
| Risk 5d forecast | |
|---|---|
| Volatility | 34.0% |
| Relative Tail Risk | -14.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.75 |
| Alpha | 74.71 |
| Character TTM | |
|---|---|
| Beta | 0.692 |
| Beta Downside | 0.057 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.56% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: ULTA Ulta Beauty
Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States, Mexico, and Kuwait. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications. It also provides beauty services, including hair, makeup, brow, and skin services at its stores. The company was formerly known as ULTA Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.19b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.87 > 1.0 |
| NWC/Revenue: 6.95% < 20% (prev 10.02%; Δ -3.07% < -1%) |
| CFO/TA 0.19 > 3% & CFO 1.36b > Net Income 1.19b |
| Net Debt (2.37b) to EBITDA (1.87b): 1.27 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.9m) vs 12m ago -4.67% < -2% |
| Gross Margin: 39.19% > 18% (prev 0.39%; Δ 3880 % > 0.5%) |
| Asset Turnover: 184.8% > 50% (prev 190.7%; Δ -5.94% > 0%) |
| Interest Coverage Ratio: 383.1 > 6 (EBITDA TTM 1.87b / Interest Expense TTM 4.12m) |
Altman Z'' 3.53
| A: 0.12 (Total Current Assets 3.37b - Total Current Liabilities 2.54b) / Total Assets 7.01b |
| B: 0.22 (Retained Earnings 1.58b / Total Assets 7.01b) |
| C: 0.24 (EBIT TTM 1.58b / Avg Total Assets 6.49b) |
| D: 0.36 (Book Value of Equity 1.58b / Total Liabilities 4.38b) |
| Altman-Z'' Score: 3.53 = A |
Beneish M -1.21
| DSRI: 1.05 (Receivables 237.4m/213.6m, Revenue 11.98b/11.36b) |
| GMI: 0.99 (GM 39.19% / 38.67%) |
| AQI: 3.99 (AQ_t 0.08 / AQ_t-1 0.02) |
| SGI: 1.05 (Revenue 11.98b / 11.36b) |
| TATA: -0.02 (NI 1.19b - CFO 1.36b) / TA 7.01b) |
| Beneish M-Score: -1.21 (Cap -4..+1) = D |
What is the price of ULTA shares?
As of February 27, 2026, the stock is trading at USD 684.27 with a total of 428,349 shares traded.
Over the past week, the price has changed by -0.75%, over one month by +3.47%, over three months by +31.33% and over the past year by +87.11%.
Over the past week, the price has changed by -0.75%, over one month by +3.47%, over three months by +31.33% and over the past year by +87.11%.
Is ULTA a buy, sell or hold?
Ulta Beauty has received a consensus analysts rating of 3.68.
Therefor, it is recommend to hold ULTA.
- StrongBuy: 9
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ULTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 677.2 | -1% |
| Analysts Target Price | 677.2 | -1% |
ULTA Fundamental Data Overview February 21, 2026
P/E Trailing = 26.4525
P/E Forward = 24.3309
P/S = 2.5925
P/B = 11.5142
P/EG = 2.8927
Revenue TTM = 11.98b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 1.87b USD
Long Term Debt = 2.02b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 842.4m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 33.43b USD (31.06b + Debt 2.57b - CCE 204.9m)
Interest Coverage Ratio = 383.1 (Ebit TTM 1.58b / Interest Expense TTM 4.12m)
EV/FCF = 32.12x (Enterprise Value 33.43b / FCF TTM 1.04b)
FCF Yield = 3.11% (FCF TTM 1.04b / Enterprise Value 33.43b)
FCF Margin = 8.69% (FCF TTM 1.04b / Revenue TTM 11.98b)
Net Margin = 9.93% (Net Income TTM 1.19b / Revenue TTM 11.98b)
Gross Margin = 39.19% ((Revenue TTM 11.98b - Cost of Revenue TTM 7.29b) / Revenue TTM)
Gross Margin QoQ = 40.44% (prev 39.15%)
Tobins Q-Ratio = 4.77 (Enterprise Value 33.43b / Total Assets 7.01b)
Interest Expense / Debt = 0.16% (Interest Expense 4.12m / Debt 2.57b)
Taxrate = 24.13% (73.4m / 304.3m)
NOPAT = 1.20b (EBIT 1.58b * (1 - 24.13%))
Current Ratio = 1.33 (Total Current Assets 3.37b / Total Current Liabilities 2.54b)
Debt / Equity = 0.98 (Debt 2.57b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.27 (Net Debt 2.37b / EBITDA 1.87b)
Debt / FCF = 2.28 (Net Debt 2.37b / FCF TTM 1.04b)
Total Stockholder Equity = 2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.35% (Net Income 1.19b / Total Assets 7.01b)
RoE = 46.87% (Net Income TTM 1.19b / Total Stockholder Equity 2.54b)
RoCE = 34.62% (EBIT 1.58b / Capital Employed (Equity 2.54b + L.T.Debt 2.02b))
RoIC = 44.43% (NOPAT 1.20b / Invested Capital 2.70b)
WACC = 7.83% (E(31.06b)/V(33.64b) * Re(8.47%) + D(2.57b)/V(33.64b) * Rd(0.16%) * (1-Tc(0.24)))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.50%
[DCF] Terminal Value 78.96% ; FCFF base≈1.02b ; Y1≈1.04b ; Y5≈1.14b
[DCF] Fair Price = 410.9 (EV 20.60b - Net Debt 2.37b = Equity 18.23b / Shares 44.4m; r=7.83% [WACC]; 5y FCF grow 1.36% → 2.90% )
EPS Correlation: 5.57 | EPS CAGR: -1.36% | SUE: 1.14 | # QB: 5
Revenue Correlation: 40.51 | Revenue CAGR: 1.23% | SUE: 3.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=7.24 | Chg7d=-0.035 | Chg30d=-0.013 | Revisions Net=-2 | Analysts=16
EPS next Year (2027-01-31): EPS=28.49 | Chg7d=+0.000 | Chg30d=+0.056 | Revisions Net=+5 | Growth EPS=+11.4% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 8.5% - Earnings Yield 3.8%)
[Growth] Growth Spread = +4.2% (Analyst 8.9% - Implied 4.7%)
P/E Forward = 24.3309
P/S = 2.5925
P/B = 11.5142
P/EG = 2.8927
Revenue TTM = 11.98b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 1.87b USD
Long Term Debt = 2.02b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 842.4m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 33.43b USD (31.06b + Debt 2.57b - CCE 204.9m)
Interest Coverage Ratio = 383.1 (Ebit TTM 1.58b / Interest Expense TTM 4.12m)
EV/FCF = 32.12x (Enterprise Value 33.43b / FCF TTM 1.04b)
FCF Yield = 3.11% (FCF TTM 1.04b / Enterprise Value 33.43b)
FCF Margin = 8.69% (FCF TTM 1.04b / Revenue TTM 11.98b)
Net Margin = 9.93% (Net Income TTM 1.19b / Revenue TTM 11.98b)
Gross Margin = 39.19% ((Revenue TTM 11.98b - Cost of Revenue TTM 7.29b) / Revenue TTM)
Gross Margin QoQ = 40.44% (prev 39.15%)
Tobins Q-Ratio = 4.77 (Enterprise Value 33.43b / Total Assets 7.01b)
Interest Expense / Debt = 0.16% (Interest Expense 4.12m / Debt 2.57b)
Taxrate = 24.13% (73.4m / 304.3m)
NOPAT = 1.20b (EBIT 1.58b * (1 - 24.13%))
Current Ratio = 1.33 (Total Current Assets 3.37b / Total Current Liabilities 2.54b)
Debt / Equity = 0.98 (Debt 2.57b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.27 (Net Debt 2.37b / EBITDA 1.87b)
Debt / FCF = 2.28 (Net Debt 2.37b / FCF TTM 1.04b)
Total Stockholder Equity = 2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.35% (Net Income 1.19b / Total Assets 7.01b)
RoE = 46.87% (Net Income TTM 1.19b / Total Stockholder Equity 2.54b)
RoCE = 34.62% (EBIT 1.58b / Capital Employed (Equity 2.54b + L.T.Debt 2.02b))
RoIC = 44.43% (NOPAT 1.20b / Invested Capital 2.70b)
WACC = 7.83% (E(31.06b)/V(33.64b) * Re(8.47%) + D(2.57b)/V(33.64b) * Rd(0.16%) * (1-Tc(0.24)))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.50%
[DCF] Terminal Value 78.96% ; FCFF base≈1.02b ; Y1≈1.04b ; Y5≈1.14b
[DCF] Fair Price = 410.9 (EV 20.60b - Net Debt 2.37b = Equity 18.23b / Shares 44.4m; r=7.83% [WACC]; 5y FCF grow 1.36% → 2.90% )
EPS Correlation: 5.57 | EPS CAGR: -1.36% | SUE: 1.14 | # QB: 5
Revenue Correlation: 40.51 | Revenue CAGR: 1.23% | SUE: 3.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=7.24 | Chg7d=-0.035 | Chg30d=-0.013 | Revisions Net=-2 | Analysts=16
EPS next Year (2027-01-31): EPS=28.49 | Chg7d=+0.000 | Chg30d=+0.056 | Revisions Net=+5 | Growth EPS=+11.4% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 8.5% - Earnings Yield 3.8%)
[Growth] Growth Spread = +4.2% (Analyst 8.9% - Implied 4.7%)